{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:37:19Z","timestamp":1747204639102,"version":"3.40.5"},"posted":{"date-parts":[[2023,3,23]]},"group-title":"In Review","reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,3,1]]},"abstract":"<title>Abstract<\/title>\n        <p>(R,S)-methadone ((R,S)-MTD) is a racemic \u00b5-opioid receptor (MOR) agonist comprised of (R)-MTD and (S)-MTD enantiomers used for the treatment of opioid use disorder (OUD) and pain. (R)-MTD is used as an OUD treatment, has high MOR potency, and is believed to mediate (R,S)-MTD\u2019s therapeutic efficacy. (S)-MTD is in clinical development as an antidepressant and is considered an N-methyl-D-aspartate receptor (NMDAR) antagonist. In opposition to this purported mechanism of action, we found that (S)-MTD does not occupy NMDARs in vivo in rats. Instead, (S)-MTD produced MOR occupancy and induced analgesia with similar efficacy as (R)-MTD. Unlike (R)-MTD, (S)-MTD was not self-administered and failed to increase locomotion or extracellular dopamine levels indicating low abuse liability. Moreover, (S)-MTD antagonized the effects of (R)-MTD in vivo and exhibited unique pharmacodynamic properties, distinct from those of (R)-MTD. Specifically, (S)-MTD acted as a MOR partial agonist with a specific loss of efficacy at the MOR-galanin 1 receptor (Gal1R) heteromer, a key mediator of the dopaminergic effects of opioids. In sum, we report novel and unique pharmacodynamic properties of (S)-MTD that are relevant to its potential mechanism of action and therapeutic use, as well as those of (R,S)-MTD.<\/p>","DOI":"10.21203\/rs.3.rs-2644719\/v1","type":"posted-content","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T15:23:36Z","timestamp":1679585016000},"source":"Crossref","is-referenced-by-count":1,"title":["Unique pharmacodynamic properties and low abuse liability of the \u00b5-opioid receptor ligand (S)-methadone"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0398-4917","authenticated-orcid":false,"given":"Michael","family":"Michaelides","sequence":"first","affiliation":[{"name":"NIH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-1503","authenticated-orcid":false,"given":"Marjorie","family":"Levinstein","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"De Oliveira","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nil","family":"Casajuana-Martin","sequence":"additional","affiliation":[{"name":"Universitat Aut\u00f2noma Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Quiroz","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reece","family":"Budinich","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Rais","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rea","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilya","family":"Ventriglia","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e0lia","family":"Llopart","sequence":"additional","affiliation":[{"name":"Universitat de Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f2nica","family":"Casad\u00f3-Anguera","sequence":"additional","affiliation":[{"name":"Universitat de Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-5753","authenticated-orcid":false,"given":"Estefan\u00eda","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona, University of Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Walther","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Glatfelter","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3678-6215","authenticated-orcid":false,"given":"David","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Zarate","sequence":"additional","affiliation":[{"name":"NIMH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1764-3825","authenticated-orcid":false,"given":"Vicent","family":"Casado","sequence":"additional","affiliation":[{"name":"University of Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Pardo","sequence":"additional","affiliation":[{"name":"Universitat Autonoma de Barcelona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1747-1779","authenticated-orcid":false,"given":"Sergi","family":"Ferre","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2644719\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2644719\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T15:53:21Z","timestamp":1681228401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2644719\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":0,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2644719\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,3,23]]},"subtype":"preprint"}}